We could not find any results for:
Make sure your spelling is correct or try broadening your search.
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech...
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; Nasdaq: XOMA) entered into a merger agreement to...
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories PR Newswire CASTRES, France and SAN FRANCISCO, March 1, 2024 Kinnate has entered into...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0.35 | 15.2173913043 | 2.3 | 2.69 | 2.2 | 560744 | 2.5720603 | CS |
26 | 1.38 | 108.661417323 | 1.27 | 2.69 | 1.15 | 1033312 | 2.4698475 | CS |
52 | -0.35 | -11.6666666667 | 3 | 4.5 | 1.04 | 647276 | 2.6088075 | CS |
156 | -24.45 | -90.221402214 | 27.1 | 27.65 | 1.04 | 309973 | 6.18374367 | CS |
260 | -37.35 | -93.375 | 40 | 48.75 | 1.04 | 299348 | 8.96443421 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions